Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532577) titled 'Intranasal Insulin to Prevent Intensive Care Unit Delirium' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Radboud University Medical Center
Condition:
Delirium - Postoperative
Intervention:
Drug: Intranasal insulin-40U
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: April 15, 2026
Target Sample Size: 30
Countries of Recruitment:
Netherlands
To know more, visit https://...